Delivery Order SPE2DR25D2204-SPE2DR26FS20M
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,408.43 for TALTZ 80 MG/ML AutoInjector on October 29, 2025, with an ultimate completion date of October 30, 2025. This firm fixed price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. The delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,399.82 for TALTZ 80 MG/ML AutoInjector on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $4,580.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL autoinjectors, with an ultimate completion date of October 30, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The product will be supplied to the place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical supplies, valued at $12,756.05 under a firm fixed price contract structure. This non-competitive delivery order, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, represents a direct fulfillment action against AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of...
- The Defense Logistics Agency awarded a $26,229.86 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injectors, with an ultimate completion date of November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on November 14, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a prescription biologic medication used to treat inflammatory...
- The Defense Logistics Agency awarded a delivery order valued at $31,434.96 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on September 23, 2025, with completion scheduled for September 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,463.75 for TALTZ 80 mg/ml autoinjector on November 5, 2025, with an ultimate completion date of November 6, 2025. This is a firm fixed price, non-set-aside contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The delivery order will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order valued at $5,055.05 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product...
- The Defense Logistics Agency awarded a $4,799.47 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector medication, with a completion date of November 17, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement for pharmaceutical supply to support federal medical procurement needs. The award was made to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $8,894.37 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on August 25, 2025, with completion scheduled for August 26, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office...
- SPE2DR25D2204Indefinite Delivery Contract
- SPE2DR25D2204-SPE2DR26FS20MDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $26,509.75 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector on November 20, 2025, with an ultimate completion date of November 21, 2025. This competitively awarded, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract utilizes no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which is also AmerisourceBergen's corporate headquarters location. TALTZ (ixekizumab) is a biologic treatment used for autoimmune conditions including psoriasis and rheumatoid arthritis. This delivery order reflects AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement needs across the Defense Health Agency and military healthcare systems. The company's substantial IDC with DLA enables it to supply a comprehensive portfolio of pharmaceuticals and medical supplies globally, supporting military health program requirements through flexible contracting mechanisms designed to ensure efficient medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.5k | 11/20/25 |